home chevron_right Respiratory Droplet Basics
Respiratory Droplet Basics
Sign up for Email Updates email
Nebraska ICAP & ASAP6 hours ago
It’s always a great tat when the ICAP/ ASAP and Ne DHHS team can get together in person!
Nebraska ICAP & ASAP8 hours ago
Time for a Way Cool Wednesday Fact!
Droplets can also be spread around through someone’s hands: if they’re infected and touch their nose and mouth and then touch something else, like a door handle or an IV pole, without cleaning their hands first. Learn more here: https://www.cdc.gov/infectioncontrol/projectfirstline/healthcare.html
#NebraskaICAP #WayCoolWednesday #InfectionControl #ProjectFirstline #InfectionPrevention #Healthcare
Droplets can also be spread around through someone’s hands: if they’re infected and touch their nose and mouth and then touch something else, like a door handle or an IV pole, without cleaning their hands first. Learn more here: https://www.cdc.gov/infectioncontrol/projectfirstline/healthcare.html
#NebraskaICAP #WayCoolWednesday #InfectionControl #ProjectFirstline #InfectionPrevention #Healthcare
Nebraska ICAP & ASAP1 day ago
You can do harm by prescribing antibiotics when they are not needed. Remind your patients that antibiotics are only needed to treat certain infections caused by bacteria, not viruses like those that cause COVID-19. To learn more visit https://www.cdc.gov/antibiotic-use
Nebraska ICAP & ASAP2 days ago
Journal Article Highlight!
This retrospective, quasi experimental study evaluated vancomycin use after the implementation of two sequential interventions; pharmacy driven MRSA nasal swab ordering protocol and 72 hour vancomycin approval process. The SAAR for antibacterial agents for resistant gram-positive infections decreased after the nasal swab protocol 1.26 to 1.13 and subsequently declined to 0.96 after implementation of 72-hour approval process. Additionally, vancomycin utilization declined from 138.9 to 125.3 days after implementation of nasal swab protocol and further declined to 112.7 days after implementation of 72-hour approval.
Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for antibiotics used for resistant gram-positive infections | Infection Control & Hospital Epidemiology | Cambridge Core - https://bit.ly/3LnICmo
#InfectionControl #InfectionPrevention #Healthcare #NEASAP #NEICAP
This retrospective, quasi experimental study evaluated vancomycin use after the implementation of two sequential interventions; pharmacy driven MRSA nasal swab ordering protocol and 72 hour vancomycin approval process. The SAAR for antibacterial agents for resistant gram-positive infections decreased after the nasal swab protocol 1.26 to 1.13 and subsequently declined to 0.96 after implementation of 72-hour approval process. Additionally, vancomycin utilization declined from 138.9 to 125.3 days after implementation of nasal swab protocol and further declined to 112.7 days after implementation of 72-hour approval.
Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for antibiotics used for resistant gram-positive infections | Infection Control & Hospital Epidemiology | Cambridge Core - https://bit.ly/3LnICmo
#InfectionControl #InfectionPrevention #Healthcare #NEASAP #NEICAP